Abstract:Significance: Reactive oxygen species (ROS) are generated during mitochondrial oxidative metabolism, and are tightly controlled through homeostatic mechanisms to maintain intracellular redox, regulating growth and proliferation in healthy cells. However, ROS production is perturbed in cancers where abnormal accumulation of ROS leads to oxidative stress and genomic instability, triggering oncogenic signaling pathways on one hand, while increasing oxidative damage and triggering ROS-dependent death signaling on the other. Recent Advances: Our review illuminates how critical interactions between ROS and oncogenic signaling, the tumor microenvironment, and DNA damage response (DDR) pathways have led to interest in ROS modulation as a means of enhancing existing anticancer strategies and developing new therapeutic opportunities. Critical Issues: ROS equilibrium exists via a delicate balance of pro-oxidant and antioxidant species within cells. "Antioxidant" approaches have been explored mainly in the form of chemoprevention, but there is insufficient evidence to advocate its routine application. More progress has been made via the "pro-oxidant" approach of targeting cancer vulnerabilities and inducing oxidative stress. Various therapeutic modalities have employed this approach, including direct ROS-inducing agents, chemotherapy, targeted therapies, DDR therapies, radiotherapy, and immunotherapy. Finally, emerging delivery systems such as "nanosensitizers" as radiotherapy enhancers are currently in development. Future Directions: While approaches designed to induce ROS have shown considerable promise in selectively targeting cancer cells and dealing with resistance to conventional therapies, most are still in early phases of development and challenges remain. Further research should endeavor to refine treatment strategies, optimize drug combinations, and identify predictive biomarkers of ROS-based cancer therapies.

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

The double-edged roles of ROS in cancer prevention and therapy

Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?

Roles of Reactive Oxygen Species in Inflammation and Cancer

Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword

Reactive Oxygen Species: a Double-Edged Sword in Oncogenesis.

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

Generation and Application of Reactive Oxygen Radicals in Cancer Treatment

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

Controlling Cancer Cells Using Reactive Oxygen Species

Targeting ROS in cancer: rationale and strategies

Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis

Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?

Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurposed Drug as an Anticancer Therapy

Reactive Oxygen Species and Colorectal Cancer

The role of reactive oxygen species in tumor treatment

Reactive oxygen species-upregulating nanomedicines towards enhanced cancer therapy

Reactive Oxygen Species: A Key Constituent in Cancer Survival

Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy

Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: From carcinogenesis toward therapy

Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells